Ascelia Pharma AB: eps_diluted
| Value | {"amount": -3.82, "concept": "ifrs-full:DilutedEarningsLossPerShare"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Ascelia Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:48:13.043004+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/321ec679-bef1-4d56-9218-df04cfcc7550
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:5493002YR9VCJJPWYN08:2022-12-31Retrieved: 2026-08-24T00:48:13.043004+02:00
Raw response sha256:
43d1adb5ca312ab8da0fc9e071699a1a…Cite as: FACTANKER, https://factanker.com/fact/321ec679-bef1-4d56-9218-df04cfcc7550
History
- no predecessors — first report